- call +1-201-465-4211
- email sales@mrinsights.biz
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Scope of the Report:
The classification of Travelers Vaccines includes Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine and other vaccines. The proportion of Hepatitis Vaccine in 2016 is about 28.94%, the proportion of Japanese Encephalitis Vaccine in 2016 is about 15.67%, and the proportion of other vaccine in 2016 is about 24.55%.
Travelers Vaccines are application in Tourists, Students, Workers and others. The most of Travelers Vaccines is Tourists, and the market share of that is about 44.41 % in 2016.
North America is the largest consumption place, with a consumption market share nearly 49.42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 19.41% in 2016. And Asia Pacific in the third largest consumption region with the consumption market share of 18.09%.
The worldwide market for Travelers Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Travelers Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Market Segment by Applications, can be divided into
Tourists
Students
Workers
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Travelers Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales, revenue and global market share of Travelers Vaccines in 2017 and 2018.
Chapter 3, the Travelers Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Travelers Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Travelers Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Meningococcal Vaccine
1.2.2 Japanese Encephalitis Vaccine
1.2.3 Yellow Fever Vaccine
1.2.4 Hepatitis Vaccine
1.2.5 Cholera Vaccine
1.2.6 Other
1.3 Market Analysis by Applications
1.3.1 Tourists
1.3.2 Students
1.3.3 Workers
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Travelers Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi Pasteur
2.2.1 Business Overview
2.2.2 Travelers Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Pasteur Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Travelers Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Travelers Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CNBG
2.5.1 Business Overview
2.5.2 Travelers Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CNBG Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi Pasteur MSD
2.6.1 Business Overview
2.6.2 Travelers Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Serum Institute of India
2.7.1 Business Overview
2.7.2 Travelers Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Serum Institute of India Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biokangtai
2.8.1 Business Overview
2.8.2 Travelers Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biokangtai Travelers Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Travelers Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Travelers Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Travelers Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Travelers Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Travelers Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Travelers Vaccines Market Analysis by Regions
4.1 Global Travelers Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Travelers Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Travelers Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Travelers Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Travelers Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Travelers Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Travelers Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Travelers Vaccines Sales and Growth Rate (2014-2019)
5 North America Travelers Vaccines by Country
5.1 North America Travelers Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Travelers Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Travelers Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Travelers Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Travelers Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Travelers Vaccines Sales and Growth Rate (2014-2019)
6 Europe Travelers Vaccines by Country
6.1 Europe Travelers Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Travelers Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Travelers Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Travelers Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Travelers Vaccines Sales and Growth Rate (2014-2019)
6.4 France Travelers Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Travelers Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Travelers Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Travelers Vaccines by Country
7.1 Asia-Pacific Travelers Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Travelers Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Travelers Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Travelers Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Travelers Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Travelers Vaccines Sales and Growth Rate (2014-2019)
7.5 India Travelers Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Travelers Vaccines Sales and Growth Rate (2014-2019)
8 South America Travelers Vaccines by Country
8.1 South America Travelers Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Travelers Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Travelers Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Travelers Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Travelers Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Travelers Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Travelers Vaccines by Countries
9.1 Middle East and Africa Travelers Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Travelers Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Travelers Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Travelers Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Travelers Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Travelers Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Travelers Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Travelers Vaccines Sales and Growth Rate (2014-2019)
10 Global Travelers Vaccines Market Segment by Type
10.1 Global Travelers Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Travelers Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Travelers Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Meningococcal Vaccine Sales Growth and Price
10.2.1 Global Meningococcal Vaccine Sales Growth (2014-2019)
10.2.2 Global Meningococcal Vaccine Price (2014-2019)
10.3 Japanese Encephalitis Vaccine Sales Growth and Price
10.3.1 Global Japanese Encephalitis Vaccine Sales Growth (2014-2019)
10.3.2 Global Japanese Encephalitis Vaccine Price (2014-2019)
10.4 Yellow Fever Vaccine Sales Growth and Price
10.4.1 Global Yellow Fever Vaccine Sales Growth (2014-2019)
10.4.2 Global Yellow Fever Vaccine Price (2014-2019)
10.5 Hepatitis Vaccine Sales Growth and Price
10.5.1 Global Hepatitis Vaccine Sales Growth (2014-2019)
10.5.2 Global Hepatitis Vaccine Price (2014-2019)
10.6 Cholera Vaccine Sales Growth and Price
10.6.1 Global Cholera Vaccine Sales Growth (2014-2019)
10.6.2 Global Cholera Vaccine Price (2014-2019)
10.7 Other Sales Growth and Price
10.7.1 Global Other Sales Growth (2014-2019)
10.7.2 Global Other Price (2014-2019)
11 Global Travelers Vaccines Market Segment by Application
11.1 Global Travelers Vaccines Sales Market Share by Application (2014-2019)
11.2 Tourists Sales Growth (2014-2019)
11.3 Students Sales Growth (2014-2019)
11.4 Workers Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Travelers Vaccines Market Forecast (2019-2024)
12.1 Global Travelers Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Travelers Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Travelers Vaccines Market Forecast (2019-2024)
12.2.2 Europe Travelers Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Travelers Vaccines Market Forecast (2019-2024)
12.2.4 South America Travelers Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Travelers Vaccines Market Forecast (2019-2024)
12.3 Travelers Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Travelers Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Travelers Vaccines Market Share Forecast by Type (2019-2024)
12.4 Travelers Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Travelers Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Travelers Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Travelers Vaccines Picture
Table Product Specifications of Travelers Vaccines
Figure Global Sales Market Share of Travelers Vaccines by Types in 2018
Ta
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
